Cardiovascular Prognosis of Subclinical Chronic Obstructive Pulmonary Disease in Patients with Suspected or Confirmed

Eduardo José Pereira Ferreira1,2,3,4, Lucas Villar Shan de Carvalho Cardoso3,5, Carlos José Oliveira de Matos6

  • 1Department of Medicine, Federal University of Sergipe, Lagarto, 49400-000, Brazil.

Insights

Patients with early chronic obstructive pulmonary disease (COPD) and coronary artery disease (CAD) face higher risks of adverse cardiovascular events. COPD independently predicts these events, even in mild cases, highlighting the need for integrated management.

Area of Science:

  • Cardiology
  • Pulmonology
  • Public Health

Background:

  • Chronic obstructive pulmonary disease (COPD) is known to worsen outcomes in patients with coronary artery disease (CAD).
  • The cardiovascular prognosis for patients with stable or early-stage COPD and concurrent CAD is not well-defined.
  • This study investigates long-term cardiovascular events in patients with subclinical or early COPD and CAD.

Purpose of the Study:

  • To determine the long-term cardiovascular event rates in patients with subclinical or early-stage COPD and concomitant CAD.
  • To assess whether COPD is an independent predictor of cardiovascular events in this population.

Main Methods:

  • A longitudinal analytical study followed 117 patients with suspected or established CAD for six years.
  • Patients were stratified into COPD (n=44) and non-COPD (n=73) groups based on spirometry.
  • Cox regression analysis was employed to evaluate the association between COPD and cardiovascular events, adjusting for CAD risk factors.

Main Results:

  • COPD patients were older, more frequently had diabetes, were more likely to smoke, and reported higher dyspnea scores.
  • COPD patients exhibited significantly higher CAD frequency and severity (severe and multivessel disease).
  • At six-year follow-up, COPD patients had a significantly higher incidence of adverse cardiovascular events (effect size, 0.720). COPD remained an independent predictor (OR: 5.13; 95% CI: 2.29-11.50).

Conclusions:

  • COPD is associated with increased coronary lesion severity and a higher number of adverse cardiovascular events in patients with CAD.
  • COPD is a significant independent predictor of long-term cardiovascular events in patients with stable, subclinical, or early-stage COPD and CAD.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
13
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K